tirzepatide obesity nejm vs Semaglutide for – NEJM, May 2025 Relevant to endocrinology, internal medicine, cardiology, obesity medicine • Tirzepatide: −20.2% weight loss at 72 wks • Semaglutide: −13.7% • Greater waist reduction Once-Weekly Tirzepatide for Obesity |
Description
Potential side effects Using tirzepatide that hasn't been stored correctly may increase the risk of adverse reactions or unexpected side effects
Choosing Victory Medical Institute for GLP-1 Therapy
Our fees are $49 for Family Medicine and $99 for Behavioral Health appointments
Semaglutide promotes weight loss by empowering you to eat fewer calories on a daily basis
